Compare ARK Genomic Revolution ETF (ARKG) vs 8x8 Inc (EGHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs 8x8 Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.88, while 8x8 Inc trades at $2.2 (market cap $290.65M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, 8x8 Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | EGHT | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $2.76 |
52-Week Low | $23.09 | $1.59 |
Market Cap | — | $290.65M |
Enterprise Value | — | $568.33M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EGHT trades at $2.05, down 0.49% today, with a bullish technical signal from moving averages. The company shows strong revenue growth with Q4 2026 earnings beating estimates at $0.11 per share versus $0.07 expected. Recent positive news includes AI product launches and industry recognition, though profitability remains weak with a net margin of just 0.22% and negative retained earnings of -$887.72 million.
Outlook is mixed with analyst consensus leaning neutral (39% buy, 43% hold). Key opportunities include AI-driven product expansion and consistent earnings beats, while risks involve high debt levels, thin margins, and competitive pressures in the CPaaS space. The stock's high P/E ratio of 205 suggests growth expectations are priced in.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About 8x8 Inc
8x8 is a provider of integrated cloud communications and contact center solutions. Its platform combines voice, video, chat, and contact center functionality into a single application to help businesses collaborate.
Read more on EGHT →
